The company’s bio-manufacturing opportunities include vaccines, complex proteins, and follow-on off-patent therapeutics.
It focuses on Recombinant Aprotinin, a protease inhibitor used in medical, research, and manufacturing applications; Vaccines for human and animal healthcare, including antiviral and anticancer applications; and follow-on off-patent biologics, including Interferon alpha 2a and 2b; Alpha-galactosidase A for treatment of Fabry disease; and Lysosomal acid lipase for the treatment of Wolman disease and cholesterol ester storage disorder and reduction of plaque in arteries.
In addition, the company’s wholly owned subsidiary, Predictive Diagnostics, Inc., (PDI) a diagnostics company, focuses on the commercial development of a proprietary approach to early diagnosis of life-threatening diseases.
PDI’s initial product focus is in the field of oncology.
The company operates in the United States and Europe.
Large Scale Biology Corporation was incorporated in 1987 and is headquartered in Vacaville, California.
